Research coauthored by RTI Health Solutions researchers will be presented at the SGO 2023 Annual Meeting on Women's Cancer.
Real-world evaluation of PARP inhibitor tolerability in advanced ovarian cancer – retrospective US cohort study. Simmons DJ, Blank SV, Nagar S, Nham T, Long GH, Davis KL, Wetherill G, Munley J, McLaurin K. Poster
